Compared to Estimates, Medical Properties (MPW) Q4 Earnings: A Look at Key Metrics

27.02.25 15:30 Uhr

For the quarter ended December 2024, Medical Properties (MPW) reported revenue of $231.84 million, down 289.5% over the same period last year. EPS came in at $0.18, compared to -$1.11 in the year-ago quarter.The reported revenue represents a surprise of +5.02% over the Zacks Consensus Estimate of $220.77 million. With the consensus EPS estimate being $0.16, the EPS surprise was +12.50%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Medical Properties performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Straight-line rent: $43.70 million versus $38.59 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -126.2% change. Revenues- Interest and other income: $11.37 million versus the three-analyst average estimate of $9.75 million. The reported number represents a year-over-year change of -121.3%. Revenues- Rent billed: $166.97 million versus $159.60 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +112.9% change. Revenues- Income from financing leases: $9.82 million compared to the $9.80 million average estimate based on two analysts. The reported number represents a change of -49.4% year over year. Net Earnings Per Share (Diluted): -$0.69 compared to the -$0.13 average estimate based on three analysts. View all Key Company Metrics for Medical Properties here>>>Shares of Medical Properties have returned +8.4% over the past month versus the Zacks S&P 500 composite's -2.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Medical Properties Trust, Inc. (MPW): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu Q4 Inc Registered Shs Unitary

Wer­bung